Loss of HLA Antigens in Metastatic Breast and Colon Cancer
Author Information
Author(s): J.R. Goepell, R.C. Rees, K. Rogers, C.J. Stoddard, W.E.G. Thomas, L. Shepherd
Primary Institution: The University of Sheffield Medical School
Hypothesis
Tumor cells that fail to express MHC class I antigens may have a growth or metastatic advantage.
Conclusion
The study found that many colon and breast carcinomas exhibit reduced expression of HLA class I antigens, which may contribute to their metastatic potential.
Supporting Evidence
- 6 out of 10 primary colon tumors showed partial or complete loss of HLA expression.
- 8 out of 10 primary breast tumors had reduced or absent beta 2m staining.
- HLA-A2 expression was absent or reduced in 4 out of 4 colon tumors and all their metastases.
- Two lymph node metastases from breast tumors showed reduced staining compared to their primary tumors.
Takeaway
Some cancer cells hide from the immune system by not showing certain markers, which helps them spread more easily.
Methodology
The study examined 10 colorectal and 10 breast carcinomas, along with their lymph node metastases, using immunohistological techniques.
Potential Biases
The selection of cases was not consecutive or unselected, which may introduce bias.
Limitations
The study only included cases with node metastases, which may not represent all tumor types.
Participant Demographics
Patients undergoing surgery for carcinoma of the breast or large bowel.
Want to read the original?
Access the complete publication on the publisher's website